<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.20722.027</object-id><label>Table 1.</label><caption><p>CDK8/19 ligands 3 and 4 adversely affect multiple organs in rats and dogs.</p><p>Wistar rats (5 male and 5 female per cohort) or Beagle dogs (2 male and 2 female per cohort for 3 and 1 male and 1 female for 4) received a daily oral dose of 3 or 4 for 14 days. In the rat study of 4, all animals were prematurely culled at 60 mg/kg and one male and female at 20 mg/kg, as a result of compound toxicity. In the dog studies, all animals were prematurely culled in the study of 3 and one female following exposure to 4 as a result of toxicity. The most severely affected organs are indicated in bold. The fold efficacious dose was calculated from a plasma PK measurement of compound exposure in satellite animals run in parallel to the tolerability study and compared to exposures at efficacious doses in human tumour&#160;xenograft models in mice (m &#8211; male and f &#8211; female).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.20722.027">http://dx.doi.org/10.7554/eLife.20722.027</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="3"><bold>Rat</bold></th><th><bold>Dog</bold></th></tr></thead><tbody><tr><td/><td><bold>Low dose</bold></td><td><bold>Mid dose</bold></td><td><bold>High dose</bold></td><td><bold>Low dose</bold></td></tr><tr><td><bold>CMPD 3</bold> <break/><bold>(mg/kg)</bold></td><td><bold>5</bold></td><td><bold>10</bold></td><td><bold>20</bold></td><td><bold>5</bold></td></tr><tr><td><bold>Target organs</bold></td><td>Bone<bold>, bone, marrow, heart, liver, lung,</bold> lymph nodes, pancreas, reproductive tract (m), spleen, thymus.</td><td><bold>Bone, bone marrow, heart, liver, lung,</bold> lymph nodes, pancreas, reproductive tract (m and f), spleen, thymus.</td><td><bold>Bone, bone marrow, heart, liver, lung,</bold> lymph nodes, pancreas, reproductive tract (m and f), spleen, thymus.</td><td>Bone marrow, <bold>gastrointestinal mucosa,</bold> <break/><bold>heart, lymphatic system</bold></td></tr><tr><td><bold>Fold of efficacious dose;</bold> <break/><bold>10&#160;mg/kg</bold></td><td>~0.3 (m) &#8211; 1.3 (f)</td><td>~0.5 (m) &#8211; 2 (f)</td><td>~1 (m) &#8211; 5 (f)</td><td>~0.3 (m) &#8211; 0.3 (f)</td></tr><tr><td><bold>CMPD 4</bold> <break/><bold>(mg/kg)</bold></td><td><bold>10</bold></td><td><bold>20</bold></td><td><bold>60</bold></td><td><bold>20</bold></td></tr><tr><td><bold>Target organs</bold></td><td><bold>Bone, bone marrow,</bold> intestines, <bold>liver, lung,</bold> lymph nodes, <bold>mammary gland,</bold> pancreas, <bold>reproductive tract (m and f), skin,</bold> spleen, <bold>stomach,</bold> thymus.</td><td><bold>Bone, bone marrow, heart,</bold> intestines, <bold>liver, lung,</bold> lymph nodes, <bold>mammary gland,</bold> pancreas, <bold>reproductive tract (m and f), skin,</bold> spleen, <bold>stomach,</bold> thymus</td><td><bold>Bone, bone marrow, brain, heart,</bold> intestines, <bold>liver, lung,</bold> lymph nodes, <bold>mammary gland,</bold> pancreas, <bold>reproductive tract (m and f), skin,</bold> spleen, <bold>stomach,</bold> thymus</td><td>Bone marrow, <bold>heart, Intestines,</bold> lymphatic system</td></tr><tr><td><bold>Fold of efficacious dose;</bold> <break/><bold>10&#160;mg/kg</bold> <break/><bold>30&#160;mg/kg</bold></td><td>~0.9 (m) &#8211; 2.4 (f) <break/>~0.3 (m) &#8211; 0.8 (f)</td><td>~3.9 (m) &#8211; 5.7 (f) <break/>~1.3 (m) &#8211; 1.9 (f)</td><td>~10.8 (m) &#8211; 23.1 (f) <break/>~3.6 (m) &#8211; 7.7 (f)</td><td>~22 (m) &#8211; 46 (f) <break/>~7 (m) &#8211; 15 (f)</td></tr></tbody></table></table-wrap>